Skip to main content
Log in

Minocycline Attenuates Microglial Activation but Fails to Mitigate Degeneration in Inferior Olive and Pontine Nuclei After Focal Cerebellar Lesion

  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

Degenerative changes in areas remote from the primary lesion site have been linked to the clinical outcome of focal brain damage, and inflammatory mechanisms have been considered to play a key role in the pathogenesis of these remote cell death phenomena. Minocycline is a tetracycline derivative, therapeutically effective in various experimental models of central nervous system (CNS) injuries that include inflammatory and apoptotic mechanisms, although recent findings have yielded mixed results. In this study, we investigated the effectiveness of minocycline treatment in reducing remote cell death. Glial activation and neuronal loss in precerebellar stations following cerebellar lesion were investigated using immunohistochemistry and Western blot techniques. Our results show that minocycline was effective in reducing microglial activations in axotomized precerebellar nuclei, but failed to mitigate either astrocytic response or neuronal loss. This finding supports the role of minocycline in modulating inflammatory response after CNS lesion and suggests its ineffectiveness in influencing degenerative phenomena in areas remote from the primary lesion site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Block F, Dihne M, Loos M (2005) Inflammation in areas of remote changes following focal brain lesion. Prog Neurobiol 75:342–365

    Article  PubMed  CAS  Google Scholar 

  2. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69

    Article  PubMed  CAS  Google Scholar 

  3. Streit WJ (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133–139

    Article  PubMed  Google Scholar 

  4. Ladeby R, Wirenfeldt M, Garcia-Ovejero D, Fenger C, Dissing-Olesen L, Dalmau I et al (2005) Microglial cell population dynamics in the injured adult central nervous system. Brain Res Brain Res Rev 48:196–206

    Article  PubMed  CAS  Google Scholar 

  5. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95:15769–15774

    Article  PubMed  CAS  Google Scholar 

  6. Festoff BW, Ameenuddin S, Arnold PM, Wong A, Santacruz KS, Citron BA (2006) Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J Neurochem 97:1314–1326

    Article  PubMed  CAS  Google Scholar 

  7. Cho KO, Kim SK, Cho YJ, Sung KW, Kim SY (2007) Regional differences in the neuroprotective effect of minocycline in a mouse model of global forebrain ischemia. Life Sci 80:2030–2035

    Article  PubMed  CAS  Google Scholar 

  8. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A et al (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69:1404–1410

    Article  PubMed  CAS  Google Scholar 

  9. Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C et al (2004) Deleterious effects of minocycline in animal models of Parkinson’s disease and Huntington’s disease. Eur J Neurosci 19:3266–3276

    Article  PubMed  Google Scholar 

  10. Sriram K, Miller DB, O’Callaghan JP (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96:706–718

    Article  PubMed  CAS  Google Scholar 

  11. Diguet E, Gross CE, Tison F, Bezard E (2004) Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Exp Neurol 189:1–4

    Article  PubMed  CAS  Google Scholar 

  12. Baptiste DC, Powell KJ, Jollimore CA, Hamilton C, LeVatte TL, Archibald ML et al (2005) Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 134:575–582

    Article  PubMed  CAS  Google Scholar 

  13. Viscomi MT, Florenzano F, Conversi D, Bernardi G, Molinari M (2004) Axotomy dependent purinergic and nitrergic co-expression. Neuroscience 123:393–404

    Article  PubMed  CAS  Google Scholar 

  14. Ryu JK, Choi HB, McLarnon JG (2006) Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington’s disease. Neuroscience 141:1835–1848

    Article  PubMed  CAS  Google Scholar 

  15. Bye N, Habgood MD, Callaway JK, Malakooti N, Potter A, Kossmann T et al (2007) Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol 204:220–233

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from MIUR and the Italian Ministry of Health to MM and to GB. English professional style editing by Claire Montagna is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Molinari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Viscomi, M.T., Latini, L., Florenzano, F. et al. Minocycline Attenuates Microglial Activation but Fails to Mitigate Degeneration in Inferior Olive and Pontine Nuclei After Focal Cerebellar Lesion. Cerebellum 7, 401–405 (2008). https://doi.org/10.1007/s12311-008-0042-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-008-0042-z

Keywords

Navigation